000 01149 a2200349 4500
005 20250513032159.0
264 0 _c19951109
008 199511s 0 0 eng d
022 _a0009-9260
024 7 _a10.1016/s0009-9260(05)83288-x
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aBrown, G
245 0 0 _aThe role of intravenous contrast enhancement in magnetic resonance imaging of prostatic carcinoma.
_h[electronic resource]
260 _bClinical radiology
_cSep 1995
300 _a601-6 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAged
650 0 4 _aFollow-Up Studies
650 0 4 _aHumans
650 0 4 _aMagnetic Resonance Imaging
_xmethods
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aNeoplasm Invasiveness
650 0 4 _aNeoplasm Staging
650 0 4 _aProstatic Neoplasms
_xpathology
650 0 4 _aSensitivity and Specificity
700 1 _aMacvicar, D A
700 1 _aAyton, V
700 1 _aHusband, J E
773 0 _tClinical radiology
_gvol. 50
_gno. 9
_gp. 601-6
856 4 0 _uhttps://doi.org/10.1016/s0009-9260(05)83288-x
_zAvailable from publisher's website
999 _c7554189
_d7554189